Buscar
Nyxoah SA
NYXHAñadir a la lista de seguimiento
1.720USD
-0.060-3.37%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
74.01MCap. mercado
PérdidaP/E TTM
Más Datos de Nyxoah SA Compañía
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Información de Nyxoah SA
Símbolo de cotizaciónNYXH
Nombre de la empresaNyxoah SA
Fecha de salida a bolsaSep 18, 2020
Director ejecutivoTaelman (Olivier)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
DirecciónRue Edouard Belin 12
CiudadMONT-SAINT-GUIBERT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísBelgium
Código postal1435
Teléfono3226121755
Sitio Webhttps://www.nyxoah.com/
Símbolo de cotizaciónNYXH
Fecha de salida a bolsaSep 18, 2020
Director ejecutivoTaelman (Olivier)
Ejecutivos de Nyxoah SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Nyxoah SA?
Los cinco principales accionistas de Nyxoah SA son: Mr. Robert Taub
¿Cuántas instituciones poseen acciones de Nyxoah SA (NYXH)?
A fecha de 2026Q1, 79 instituciones poseen acciones de Nyxoah SA, con un valor de mercado combinado de aproximadamente 9.38M, lo que representa el 21.47% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -824223.00.